GlaxoSmithKline Pakistan Limited: Shariah Disclosure for the Half Year ended June 30, 2026
Summary
GlaxoSmithKline Pakistan Limited filed this notice with the Pakistan Stock Exchange on 15 Sep 2026. The filing as submitted: “Shariah Disclosure for the Half Year ended June 30, 2026”.
Read the original filingGlaxoSmithKline Pakistan Limited (GLAXO) on Nafa
Last price Rs 336.89 · Pharmaceuticals · You can own GLAXO shares from your phone.
More GLAXO announcements
- NoticeTransmission of Quarterly Report for the Period Ended September 30, 2026
- Financial resultGlaxoSmithKline Pakistan Limited reported a revenue of Rs 48.11 billion for the nine months ended September 30, 2026Filed as: Financial Results for the Quarter Ended September 30, 2026
- NoticeBoard Meeting Quarter 3-2026
- NoticeCredit of Interim Cash Dividend
- NoticeAppointment of Chief Financial Officer
- NoticeAppointment of Executive Director
Source: GlaxoSmithKline Pakistan Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.